Monitoring cell viability is essential for evaluating drug effects in biomedical research. Traditional assays often rely on destructive end-point measurements, limiting their ability to capture dynamic cellular responses. Scalable, non-destructive technologies that enable real-time analysis of cell viability are critical for advancing both efficacy and safety testing.

In this application note, you will explore:

  • How CytoTronics’ electrical imaging platform captures real-time changes in cell proliferation and viability
  • Multi-parametric data characterizing the response of lung adenocarcinoma cells to the chemotherapeutic drug Paclitaxel over time
  • Comparisons between impedance-based results and traditional end-point cell viability assays in assessing Paclitaxel efficacy and dose response

Measuring chemotherapy response in human lung carcinoma cells.